期刊文献+

泌尿系感染患者病原菌分布及耐药性分析 被引量:5

Distribution and drug resistance of pathogens in patients with urinary tract infection
下载PDF
导出
摘要 目的:分析泌尿系感染患者病原菌分布情况及耐药性。方法:2017年1月-2018年12月收集门诊及住院患者尿液标本分离培养获得病原菌9252份,进行细菌鉴定及药敏试验。结果:尿培养标本9252份,检出病原菌1688株,检出率为18.2%;其中革兰阴性菌1285株(76.1%),革兰阳性菌322株(19.1%),真菌81株(4.8%);检出率最高的前5位病原菌依次为大肠埃希菌、肺炎克雷伯菌、粪肠球菌、表皮葡萄球菌、奇异变形杆菌。结论:泌尿系感染病原菌以革兰阴性菌为主,大肠埃希菌是主要病原菌,随多重耐药种类和数量不断增加,临床医生应根据药敏结果,正确合理使用抗菌药物,提高临床抗感染治疗的效果。 Objective:To explore the distribution and drug resistance of pathogens in patients with urinary tract infection.Methods:From January 2017 to December 2018,urine samples of outpatients and inpatients were selected and 9252 pathogenic bacteria were isolated and cultured,bacteria identification and drug sensitivity test were carried out.Results:In 9252 urine culture samples,1688 pathogenic bacteria were detected,the detection rate was 18.2%.Among them,1285(76.1%)were Gram-negative bacteria,322(19.1%)were Gram-positive bacteria,81(4.8%)were fungi.The top five pathogens with the highest detection rate were Escherichia coli,Klebsiella pneumoniae,Enterococcus faecalis,Staphylococcus epidermidis and Proteus mirabilis.Conclusion:Gram negative bacteria are the main pathogens of urinary tract infection,and Escherichia coli is the main pathogen,with the increase of the types and quantity of multidrug resistance,clinicians should use antibiotics correctly and reasonably according to the results of drug sensitivity,so as to improve the effect of clinical anti infection treatment.
作者 刘力娟 王厚芳 孙芾 Liu Lijuan;Wang Houfang;Sun Fei(Laboratory,Beijing United Family Hospital,Beijing 100015)
出处 《中国社区医师》 2020年第5期139-141,共3页 Chinese Community Doctors
关键词 泌尿系感染 尿培养 病原菌 耐药性 Urinary tract infection Urine culture Pathogenic bacteria Drug resistance
  • 相关文献

参考文献6

二级参考文献61

  • 1赵建平,周艳萍,白晓红,李风娥,杨国香.泌尿系感染的病原菌分布及耐药性分析[J].中华医院感染学杂志,2004,14(3):350-352. 被引量:77
  • 2袁宏.泌尿系感染病原菌现状及体外耐药性监测[J].中华医院感染学杂志,2005,15(1):108-109. 被引量:36
  • 3刘少娟,彭湘明,何雅军,谭见容.泌尿系感染病原菌分布及耐药性分析[J].广州医药,2006,37(6):55-58. 被引量:3
  • 4Burgess DS,Rapp RP.Bugs versus drugs:addressing the pharma-cist's challenge[J],Am J Health syst Pharm,2008,65(9 suppl 2):S4-15.
  • 5Wagenlehner FM,Weidner W,Naber KG.Antibiotics in urology: new essentials[J]. Urol Clin North Am,2008,35(1):69-79.
  • 6Miftode E,Domeanu O,Leca D,et al.Antimicrobial resistance profile of Esherichia coli and Klebsiella spp.from urine in the in-fectious diseases hospital Iasi[J].Rev Med Chir SocMed Nat Iasi,2008,112(2):478-482.
  • 7Katsumi S,Kazushi T,Hiroshi O,et al.Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20year period(1983-2002)at a singleinstitution in Japan[J].Jpn J Infect Dis,2005,58(1):303-308.
  • 8Jeffres MN,Shuster JE,Barclay SM.Treatment of ciprofloxacin nonsusceptible urinary tract infections with ciprofloxacin[J].Ann Pharmacother,2011,45(6):824-825.
  • 9Stein GE,Schooley SL,Nicolau DP.Urinary bactericidal activity of single doses(250,500,750and 1000mg)of levofloxacin against fluoroquinolone-resistant strains of Escherichiacoli[J].Int J Antimicrob Agents,2008,32(4):320-325.
  • 10林艳,杨振强.356株尿路感染病原菌分布及耐药情况[J].浙江预防医学,2008,20(6):20-20. 被引量:2

共引文献81

同被引文献39

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部